Bronchogen

Bronchogen
Bronchogen (Ala–Glu–Asp–Leu) is a research peptide described in bioregulator literature as a respiratory-targeting compound. While preclinical sources suggest potential effects on bronchial tissue, there is currently no robust independent clinical evidence demonstrating DNA-stabilizing, bronchodilatory, or therapeutic effects in human respiratory disease.
$180.00
$167.00
Buy more, save more!
-
Save 1%
Buy 3, get $2.50 off each
$167.00Per item: $164.50Total price: $493.50 -
Save 2%
Buy 5, get $3.75 off each
$167.00Per item: $163.25Total price: $816.25 -
Save 4%
Buy 10, get $7.50 off each
$167.00Per item: $159.50Total price: $1,595.00
99+% PURITY
All peptides are third-party lab tested.
SECURE PAYMENT
Your payments are secure with our private security network.
FREE SHIPPING
for orders over $250
Bronchogen is a synthetic tetrapeptide with the amino acid sequence Ala–Glu–Asp–Leu (AEDL). It is part of a class of short peptides studied within the Khavinson bioregulator research framework, where tissue-specific peptides are investigated for potential regulatory effects on gene expression in experimental biological systems.
Bronchogen (AEDL) has been investigated in bronchial epithelial cell models, where studies from the same research lineage report changes in gene expression and protein markers associated with epithelial differentiation and cellular function. These findings are primarily derived from in vitro cell culture experiments, with some supporting animal model data.
The peptide is studied in laboratory settings within a broader hypothesis that short peptides may influence tissue-specific gene expression patterns in bronchial epithelium. Reported experimental observations include modulation of genes involved in epithelial structure and differentiation, based on molecular assays conducted in controlled preclinical environments.
| Strength Variation |
|---|

There are no reviews yet.